Decibel Therapeutics, Inc. DBTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

30/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

共有 50 笔近期内部人交易记录记录，涉及 Decibel Therapeutics, Inc. (DBTX), 包括 23 笔买入 和 20 笔卖出. 内部人买入总额为 $3.3M 内部人卖出总额为 $6.91M.

近期活跃的重要内部人包括 Mclaughlin Kevin F, Reid Laurence, Kapusta Matthew C. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — DBTX

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2023-09-25	Mclaughlin Kevin F	Director	股份退回	5,000	$4.78	$23.9K	-
2023-09-25	Reid Laurence	See Remarks	股份退回	1,072,539	$4.40	$4.72M	-
2023-09-25	Kapusta Matthew C	Director	股份退回	10,000	$3.34	$33.4K	-
2023-09-25	Finger Alison Cecily	Director	股份退回	20,000	$6.20	$124K	-
2023-09-25	Carson William H.	Director	股份退回	20,000	$8.42	$168.4K	-
2023-09-25	Trask Anna	Chief People Officer	股份退回	137,302	$4.40	$604.13K	-
2023-09-25	Lee John Jui-jen	Chief Development Officer	股份退回	232,003	$4.40	$1.02M	-
2023-09-25	Nochur Sara	Director	股份退回	20,000	$6.20	$124K	-
2023-06-13	Mclaughlin Kevin F	Director	限制性股票授予 (RSU)	5,000	$4.78	$23.9K	5,000
2023-06-13	Finger Alison Cecily	Director	限制性股票授予 (RSU)	5,000	$4.78	$23.9K	5,000
2023-06-13	Carson William H.	Director	限制性股票授予 (RSU)	5,000	$4.78	$23.9K	5,000
2023-06-13	Nochur Sara	Director	限制性股票授予 (RSU)	5,000	$4.78	$23.9K	5,000
2023-03-19	Kapusta Matthew C	Director	未知	-	-	-	-
2023-03-19	Kapusta Matthew C	Director	限制性股票授予 (RSU)	10,000	$3.34	$33.4K	10,000
2023-03-16	Reid Laurence	See Remarks	限制性股票授予 (RSU)	72,000	$3.73	$268.56K	72,000
2023-01-26	Trask Anna	Chief People Officer	限制性股票授予 (RSU)	45,000	-	-	45,000
2023-01-26	Lee John Jui-jen	Chief Development Officer	限制性股票授予 (RSU)	45,000	-	-	45,000
2022-10-10	Mclaughlin Kevin F	Director	未知	-	-	-	-
2022-10-10	Mclaughlin Kevin F	Director	限制性股票授予 (RSU)	20,000	-	-	20,000
2022-10-07	Murphy James B	Officer	未知	-	-	-	-
2022-06-17	Thompson Peter A.	10 Percent Owner	限制性股票授予 (RSU)	10,000	$2.30	$23K	10,000
2022-06-17	Exter Neil	10 Percent Owner	限制性股票授予 (RSU)	10,000	$2.30	$23K	10,000
2022-06-17	Finger Alison Cecily	Director	限制性股票授予 (RSU)	10,000	$2.30	$23K	10,000
2022-06-17	Carson William H.	Director	限制性股票授予 (RSU)	10,000	$2.30	$23K	10,000
2022-06-17	Nochur Sara	Director	限制性股票授予 (RSU)	10,000	-	-	10,000
2022-02-25	Reid Laurence	See Remarks	限制性股票授予 (RSU)	187,500	$3.50	$656.25K	187,500
2022-02-25	Trask Anna	See Remarks	限制性股票授予 (RSU)	52,500	$3.50	$183.75K	52,500
2022-02-25	Leiderman Elisabeth	Chief Financial Officer	限制性股票授予 (RSU)	52,500	$3.50	$183.75K	52,500
2022-02-25	Lee John Jui-jen	Chief Development Officer	限制性股票授予 (RSU)	52,500	$3.50	$183.75K	52,500
2022-01-03	Trask Anna	See Remarks	知情卖出	377	$5.03	$1.9K	1,864
2021-12-03	Finger Alison Cecily	Director	未知	-	-	-	-
2021-12-03	Finger Alison Cecily	Director	限制性股票授予 (RSU)	20,000	$6.20	$124K	20,000
2021-12-03	Nochur Sara	Director	未知	-	-	-	-
2021-12-03	Nochur Sara	Director	限制性股票授予 (RSU)	20,000	$6.20	$124K	20,000
2021-12-02	Trask Anna	See Remarks	知情卖出	378	$6.34	$2.39K	2,242
2021-11-03	Trask Anna	See Remarks	知情卖出	378	$8.34	$3.15K	7,533
2021-11-02	Trask Anna	See Remarks	知情卖出	4,913	$8.31	$40.83K	7,911
2021-10-14	Trask Anna	See Remarks	知情卖出	5,364	$7.55	$40.48K	12,824
2021-09-15	Reid Laurence	President and Chief Executive	知情买入	10,000	$7.64	$76.4K	25,849
2021-08-16	Hu Cynthia W.	Officer	未知	-	-	-	-
2021-08-16	Hu Cynthia W.	General Counsel	限制性股票授予 (RSU)	150,000	$7.37	$1.11M	150,000
2021-06-02	Carson William H.	Director	未知	-	-	-	-
2021-06-02	Carson William H.	Director	限制性股票授予 (RSU)	20,000	$8.42	$168.4K	20,000
2021-02-17	Gv 2016 Gp, L.l.c.	10 Percent Owner	转换（卖出）	5,000,000	-	-	-
2021-02-17	Gv 2017 Gp, L.l.c.	10 Percent Owner	转换（卖出）	6,250,000	-	-	-
2021-02-17	Gv 2019 Gp, L.l.c.	10 Percent Owner	转换（卖出）	4,344,048	-	-	-
2021-02-17	Regeneron Pharmaceuticals, Inc.	10 Percent Owner	转换（卖出）	14,000,000	-	-	-
2021-02-17	Longevity Fund 2 Lp	10 Percent Owner	转换（卖出）	79,143	-	-	-
2021-02-17	Orbimed Advisors Llc	10 Percent Owner	转换（卖出）	1,158,412	-	-	-
2021-02-17	Glaxosmithkline Plc	Director	转换（卖出）	1,737,619	-	-	-